Gliomas infiltrate surrounding brain matter rather than forming distinct, easy-to-remove masses, making surgical precision a critical factor in patient outcomes. Dr. Cohen-Gadol, founder of the ATLAS Institute of Brain and Spine, employs a multi-layered approach to this challenge. By utilizing fluorescence-guided resection, he enables tumor margins to glow under specialized microscopes, a technique that significantly improves upon traditional visual identification. His methodology further incorporates real-time molecular analysis via mass spectrometry and awake brain mapping, which allows surgeons to preserve vital speech and motor functions during the procedure.

Beyond the operating room, the integration of AI-assisted 3D surgical simulation allows for the mapping of white matter pathways before a single incision is made. This focus on maximizing safe resection is particularly vital for Grade III and IV gliomas, where the extent of tumor removal directly influences the success of follow-up radiation and chemotherapy. Dr. Cohen-Gadol, a recipient of the Vilhelm Magnus Medal, also leads the Neurosurgical Atlas, an educational platform serving over 70,000 medical professionals. For patients facing complex diagnoses, the practice provides virtual second-opinion reviews, enabling families to evaluate treatment strategies and the necessity of travel to his facilities at Cedars-Sinai Medical Center or Saint John's Health Center.